Saleem_2021_Metab.Brain.Dis_36_1231

Reference

Title : Antiparkinsonian activity of Cucurbita pepo seeds along with possible underlying mechanism - Saleem_2021_Metab.Brain.Dis_36_1231
Author(s) : Saleem U , Shehzad A , Shah S , Raza Z , Shah MA , Bibi S , Chauhdary Z , Ahmad B
Ref : Metabolic Brain Disease , 36 :1231 , 2021
Abstract :

Cucurbita pepo is used as a vegetable in Pakistan and its seeds are also rich in tocopherol. Data showed the pivotal role of tocopherol in the treatment of Parkinson's disease (PD). The current study was designed to probe into the antiparkinson activity of methanolic extract of C. pepo (MECP) seeds in the haloperidol-induced Parkinson rat model. Behavioral studies showed improvement in motor functions. The increase in catalase, superoxide dismutase, glutathione levels whereas the decreases in the malondialdehyde and nitrite levels were noted in a dose-dependent manner. Acetylcholine-esterase (AchE) activity was increased. Molecular docking results revealed significant binding interaction of selected phytoconstituents within an active site of target protein AchE (PDB ID: 4EY7). Furthermore, alpha-synuclein was up regulated with down regulation of TNF-alpha and IL-1beta in the qRT-PCR study. Subsequently, ADMET results on the basis of structure to activity predictions in terms of pharmacokinetics and toxicity estimations show that selected phytochemicals exhibited moderately acceptable properties. These properties add knowledge towards the structural features which could improve the bioavailability of selected phytochemicals before moving towards the initial phase of the drug development. Our integrated drug discovery scheme concluded that C. pepo seeds could ameliorate symptoms of PD and may prove a lead remedy for the treatment of PD.

PubMedSearch : Saleem_2021_Metab.Brain.Dis_36_1231
PubMedID: 33759084

Related information

Citations formats

Saleem U, Shehzad A, Shah S, Raza Z, Shah MA, Bibi S, Chauhdary Z, Ahmad B (2021)
Antiparkinsonian activity of Cucurbita pepo seeds along with possible underlying mechanism
Metabolic Brain Disease 36 :1231

Saleem U, Shehzad A, Shah S, Raza Z, Shah MA, Bibi S, Chauhdary Z, Ahmad B (2021)
Metabolic Brain Disease 36 :1231